In this podcast, experts discuss ASCO’s recent endorsement of ASTRO’s guideline for radiation therapy for non-small cell lung cancer.
Dr. Julie Brahmer from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins shares details about the recent FDA approval of nivolumab (Opdivo) for advanced non-small cell lung cancer. She explains how this impacts the treatment of lung cancer.
People with cancer often take dietary and herbal products to boost health, improve nutrition, or reduce treatment side effects. However, these products are not approved by the U.S. Food and Drug Administration like drugs and may interact with standard cancer treatments.
First in this podcast series, Dr. Brian Rini shares his perspective on current and new approaches to kidney cancer treatment.
Misinformation about cancer is everywhere on the Internet. So how can you know what’s scientifically accurate when some of these myths may sound perfectly plausible?
In this podcast, Certified Lymphedema Therapist and patient Dr. Judith Nudelman shares what lymphedema is and how to manage it.
After two decades of coping with advanced colorectal cancer, metastases in her lungs and liver, and a diagnosis of breast cancer, Margaret G. Werts, PhD, has learned how to maintain a sense of control and appreciate the small moments.
The side effects of throat cancer treatment left Doug Bradley nearly deaf and unable to eat the foods he loves. And yet, he still has no regrets.
Get highlights of four studies that address ways to improve the care of men with prostate cancer. Results include the identification of a potential risk factor, better ways to select the best treatment option, and new insight into the debate over prostate-specific antigen (PSA) screening.
Recognizing the dramatic advances in the treatment of chronic lymphocytic leukemia (CLL), ASCO named the approval of four new drugs for this disease in 2014 as its first “Advance of the Year.”